Paper Details

  1. Home
  2. Paper Details

A pooled analysis of the efficacy of fesoterodine for the treatment of overactive bladder, and the relationship between safety, co-morbidity and polypharmacy in patients aged 65 years or older.

Author: Angulo CuestaJavier, ArumiDaniel, CarlssonMartin, HaabFrancois, HerschornSender, NtaniosFady, OelkeMatthias, WaggAdrian

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study examines the efficacy and safety of fesoterodine, an antimuscarinic medication for overactive bladder (OAB), in older patients.
Paper Details　
Original Abstract of the Article :
overactive bladder (OAB) is a common condition in older persons. Antimuscarinic treatment remains the mainstay of treatment of OAB but clinicians have been reluctant to prescribe this to older patients. This study examined efficacy and safety information from patients >65 in fesoterodine trials to r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/ageing/afw252

データ提供：米国国立医学図書館（NLM）

Fesoterodine for Overactive Bladder: A Pooled Analysis of Efficacy and Safety

Overactive bladder (OAB) is a common condition, particularly among older adults. This study examines the efficacy and safety of fesoterodine, an antimuscarinic medication, for the treatment of OAB in patients aged 65 years or older. The researchers conducted a pooled analysis of data from multiple clinical trials, investigating the relationship between treatment-emergent adverse events (TEAEs), coexisting medications, and co-morbidities.

Fesoterodine: A Treatment Option for Overactive Bladder in Older Adults

This research is like a careful analysis of a desert ecosystem, considering the interconnectedness of different factors. The study provides valuable insights into the efficacy and safety of fesoterodine in managing OAB in older adults. The findings offer a balanced perspective on the benefits and potential risks of this medication, aiding clinicians in making informed decisions for their patients.

Navigating Overactive Bladder with Confidence

Overactive bladder can be a disruptive and embarrassing condition, impacting an individual's quality of life. This research provides valuable information about fesoterodine, a treatment option for OAB in older adults. Understanding the efficacy and safety of this medication can empower patients and healthcare providers to make informed decisions about treatment, enhancing the management of OAB and improving daily well-being.

Dr.Camel's Conclusion

This research provides a thorough analysis of fesoterodine's efficacy and safety in managing OAB in older adults. It's like a desert explorer carefully assessing a new water source, weighing its benefits and potential risks. The study offers valuable insights for both patients and healthcare providers seeking to effectively manage OAB and improve the quality of life for older adults.

Date :
  1. Date Completed 2018-01-29
  2. Date Revised 2018-11-02
Further Info :

Pubmed ID

28057620

DOI: Digital Object Identifier

10.1093/ageing/afw252

Related Literature

Article Analysis
・Side Effects of fesoterodine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.